107 related articles for article (PubMed ID: 12210808)
1. Bcl-2 family of proteins in indolent B-cell non-Hodgkin's lymphoma: study of 116 cases.
Agarwal B; Naresh KN
Am J Hematol; 2002 Aug; 70(4):278-82. PubMed ID: 12210808
[TBL] [Abstract][Full Text] [Related]
2. Bcl-2, Bcl-X, Bax, and Bak expression in short- and long-lived patients with diffuse large B-cell lymphomas.
Bairey O; Zimra Y; Shaklai M; Okon E; Rabizadeh E
Clin Cancer Res; 1999 Oct; 5(10):2860-6. PubMed ID: 10537354
[TBL] [Abstract][Full Text] [Related]
3. Acquired resistance to rituximab is associated with chemotherapy resistance resulting from decreased Bax and Bak expression.
Olejniczak SH; Hernandez-Ilizaliturri FJ; Clements JL; Czuczman MS
Clin Cancer Res; 2008 Mar; 14(5):1550-60. PubMed ID: 18316580
[TBL] [Abstract][Full Text] [Related]
4. Mcl-1 and Bcl-2/Bax ratio are associated with treatment response but not with Rai stage in B-cell chronic lymphocytic leukemia.
Saxena A; Viswanathan S; Moshynska O; Tandon P; Sankaran K; Sheridan DP
Am J Hematol; 2004 Jan; 75(1):22-33. PubMed ID: 14695629
[TBL] [Abstract][Full Text] [Related]
5. Expression and localization of Bcl-2 related proteins in human ovarian cancers.
Witty JP; Jensen RA; Johnson AL
Anticancer Res; 1998; 18(2B):1223-30. PubMed ID: 9615792
[TBL] [Abstract][Full Text] [Related]
6. In vivo patterns of Bcl-2 family protein expression in breast carcinomas in relation to apoptosis.
Rochaix P; Krajewski S; Reed JC; Bonnet F; Voigt JJ; Brousset P
J Pathol; 1999 Mar; 187(4):410-5. PubMed ID: 10398099
[TBL] [Abstract][Full Text] [Related]
7. Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells.
Zhang CL; Kamarashev J; Qin JZ; Burg G; Dummer R; Döbbeling U
J Pathol; 2003 Jun; 200(2):249-54. PubMed ID: 12754746
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB
Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
[TBL] [Abstract][Full Text] [Related]
9. Expression of the bcl-2 family of genes in the course of keratinocyte differentiation.
Thomková H; Fujimoto W; Arata J
Eur J Dermatol; 1999; 9(3):191-6. PubMed ID: 10210783
[TBL] [Abstract][Full Text] [Related]
10. Proteomic analysis of apoptotic pathways reveals prognostic factors in follicular lymphoma.
Gulmann C; Espina V; Petricoin E; Longo DL; Santi M; Knutsen T; Raffeld M; Jaffe ES; Liotta LA; Feldman AL
Clin Cancer Res; 2005 Aug; 11(16):5847-55. PubMed ID: 16115925
[TBL] [Abstract][Full Text] [Related]
11. [Expressions of Bcl-2, Bax and Bak proteins in liver tissues of hepatitis B patients and their significance].
Zhang B; Zhang D; Ma Y
Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):74-6. PubMed ID: 10488411
[TBL] [Abstract][Full Text] [Related]
12. Cluster analysis of apoptosis-associated bcl2 family proteins in diffuse large B-cell lymphomas. Relations with the apoptotic index, the proliferation profile and the B-cell differentiation immunophenotypes.
Bai M; Skyrlas A; Agnantis NJ; Kamina S; Kitsoulis P; Kanavaros P
Anticancer Res; 2004; 24(5A):3081-8. PubMed ID: 15517919
[TBL] [Abstract][Full Text] [Related]
13. Triggering of apoptosis by Puma is determined by the threshold set by prosurvival Bcl-2 family proteins.
Callus BA; Moujallad DM; Silke J; Gerl R; Jabbour AM; Ekert PG; Vaux DL
J Mol Biol; 2008 Dec; 384(2):313-23. PubMed ID: 18835564
[TBL] [Abstract][Full Text] [Related]
14. Interferon-alpha-induced apoptosis in U266 cells is associated with activation of the proapoptotic Bcl-2 family members Bak and Bax.
Panaretakis T; Pokrovskaja K; Shoshan MC; Grandér D
Oncogene; 2003 Jul; 22(29):4543-56. PubMed ID: 12881711
[TBL] [Abstract][Full Text] [Related]
15. [Apoptosis-antagonizing protein Bcl-2 expression, distribution in non-Hodgkin's lymphoma and its clinical significance].
Chen X; Huang G; Wang W
Zhonghua Zhong Liu Za Zhi; 1997 Mar; 19(2):140-2. PubMed ID: 10743081
[TBL] [Abstract][Full Text] [Related]
16. Expression of the NF-kappaB targets BCL2 and BIRC5/Survivin characterizes small B-cell and aggressive B-cell lymphomas, respectively.
Tracey L; Pérez-Rosado A; Artiga MJ; Camacho FI; Rodríguez A; Martínez N; Ruiz-Ballesteros E; Mollejo M; Martinez B; Cuadros M; Garcia JF; Lawler M; Piris MA
J Pathol; 2005 Jun; 206(2):123-34. PubMed ID: 15880597
[TBL] [Abstract][Full Text] [Related]
17. Apoptotic-regulatory and complement-protecting protein expression in chronic lymphocytic leukemia: relationship to in vivo rituximab resistance.
Bannerji R; Kitada S; Flinn IW; Pearson M; Young D; Reed JC; Byrd JC
J Clin Oncol; 2003 Apr; 21(8):1466-71. PubMed ID: 12697868
[TBL] [Abstract][Full Text] [Related]
18. Bcl-2 family gene modulation during spontaneous apoptosis of B-chronic lymphocytic leukemia cells.
Sanz L; Garcia-Marco JA; Casanova B; de La Fuente MT; García-Gila M; Garcia-Pardo A; Silva A
Biochem Biophys Res Commun; 2004 Mar; 315(3):562-7. PubMed ID: 14975737
[TBL] [Abstract][Full Text] [Related]
19. CD45 expression in low-grade B-cell non-Hodgkin's lymphomas.
Carulli G; Cannizzo E; Zucca A; Buda G; Orciuolo E; Marini A; Petrini M
Leuk Res; 2008 Feb; 32(2):263-7. PubMed ID: 17692374
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-mediated protection against etoposide-induced apoptosis in BJA-B B cell lymphoma cells: role of Bcl-2 and caspase proteins.
Blood A; Edwards CJ; Ishii HH; Pat BK; Bryson G; Sculley TB; Gobe GC
Arch Virol; 2004 Feb; 149(2):289-302. PubMed ID: 14745596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
